Clinical Trial Update: Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating adjuvant chemotherapy in breast cancer patients who had partial or complete response to neoadjuvant chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Breast Cancer
• Invasive Ductal Breast Cancer
• Mucinous Breast Cancer
• Tubular Breast Cancer

Snippet

Sponsor: RenJi Hospital | Conditions: Invasive Ductal Breast Cancer, Tubular Breast Cancer | Phase 3 | Status: UNKNOWN